106 related articles for article (PubMed ID: 2133287)
1. Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
Pignol B; Lonchampt MO; Chabrier PE; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S83-91. PubMed ID: 2133287
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the priming effects of platelet-activating factor on the release of interleukin-1 from lipopolysaccharide-stimulated rat spleen macrophages.
Pignol B; Henane S; Chaumeron S; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S93-9. PubMed ID: 2133288
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance.
Gahring LC; Daynes RA
J Immunol; 1986 Apr; 136(8):2868-74. PubMed ID: 2420872
[TBL] [Abstract][Full Text] [Related]
4. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
5. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells.
Pignol B; Hénane S; Sorlin B; Rola-Pleszczynski M; Mencia-Huerta JM; Braquet P
J Immunol; 1990 Aug; 145(3):980-4. PubMed ID: 2373865
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response.
Maestre C; Zarco P; Gómez-Guerrero C; González E; Herrero-Beaumont G; Braquet M; Egido J
J Lipid Mediat; 1990; 2 Suppl():S151-9. PubMed ID: 1966813
[TBL] [Abstract][Full Text] [Related]
8. The synergism between platelet-activating factor and interleukin-1 on cartilage breakdown.
Howat D; Desa F; Chander C; Moore A; Willoughby D
J Lipid Mediat; 1990; 2 Suppl():S143-9. PubMed ID: 2133279
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
10. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
[TBL] [Abstract][Full Text] [Related]
11. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes.
Kupper TS; McGuire J
J Invest Dermatol; 1986 Nov; 87(5):570-3. PubMed ID: 3534102
[TBL] [Abstract][Full Text] [Related]
12. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
[TBL] [Abstract][Full Text] [Related]
13. Effects of ginkgolides on interleukin-1, tumor necrosis factor-alpha and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro.
Du ZY; Li XY
Arzneimittelforschung; 1998 Dec; 48(12):1126-30. PubMed ID: 9893925
[TBL] [Abstract][Full Text] [Related]
14. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro].
Dong JC; Li M; Shi ZY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427
[TBL] [Abstract][Full Text] [Related]
15. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes.
Pignol B; Hénane S; Mencia-Huerta JM; Rola-Pleszczynski M; Braquet P
Prostaglandins; 1987 Jun; 33(6):931-9. PubMed ID: 3313526
[TBL] [Abstract][Full Text] [Related]
17. Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro.
Gahring L; Baltz M; Pepys MB; Daynes R
Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1198-202. PubMed ID: 6608106
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
Zhou W; Chao W; Levine BA; Olson MS
Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
[TBL] [Abstract][Full Text] [Related]
19. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes.
Shimada A; Ota Y; Sugiyama Y; Sato S; Kume K; Shimizu T; Inoue S
J Invest Dermatol; 1998 Jun; 110(6):889-93. PubMed ID: 9620295
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs.
Qian C; Guo ZM; Peters CJ; Liu CT
J Lipid Mediat; 1993 Jul; 7(3):223-37. PubMed ID: 8219003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
